Latest Advances in Thrombosis Prevention & Management for 2025 скачать в хорошем качестве

Latest Advances in Thrombosis Prevention & Management for 2025

This program is supported through an independent educational grant from Johnson & Johnson and Bristol Myers Squibb. It is intended exclusively for healthcare professionals in the United States. In this 45-minute live webinar, national cardiovascular experts Jennifer Rymer, MD and Siddharth M. Patel, MD provide practical, case-based insights on optimizing thrombosis management in acute coronary syndrome (ACS), atrial fibrillation (AF), and secondary stroke prevention (SSP). Drawing on the latest guidelines and clinical trial evidence, webinar demonstrates how to apply validated risk assessment tools and tailor antithrombotic therapy to balance thrombotic and bleeding risk in high-risk patients. Accreditation: 0.75 AMA PRA Category 1 Credit™. This interactive session features clinical polling, real-world scenarios, and expert Q&A—helping healthcare professionals sharpen their ability to identify high-risk patients and select the right anticoagulation strategies across diverse cardiovascular settings. Session Highlights Risk tools in action: Use CHA₂DS₂-VASc, HAS-BLED, and GRACE scoring systems to stratify risk in AF, ACS, and SSP. Tailored treatment plans: Optimize DOAC selection and dosing based on patient-specific thrombotic and bleeding risks. Avoid the risk-treatment paradox: Improve adherence to evidence-based strategies while addressing bleeding concerns. Real-time learning: Participate in live polling and expert-led Q&A to address everyday clinical decision-making challenges. Who Should Watch Cardiologists Electrophysiologists Interventional Cardiologists Cardiac Surgeons Primary Care Physicians Nurse Practitioners Physician Assistants Other U.S.-based HCPs managing thrombosis in AF, ACS, or stroke Presented by Jennifer A. Rymer, MD, MBA, MHS – is the John Bush Simpson Assistant Professor of Medicine at Duke University School of Medicine and a faculty member at the Duke Clinical Research Institute. She is an interventional cardiologist specializing in coronary and peripheral vascular interventions. Dr. Rymer’s research focuses on clinical trials and implementation science in acute myocardial infarction and peripheral artery disease, with grant funding from the NIH, American Heart Association, and industry partners. Siddharth M. Patel, MD, MPH – is an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital, an Instructor of Medicine at Harvard Medical School, and an Investigator in the TIMI Study Group. He earned his medical degree from UT Southwestern Medical School and an MPH from the Harvard T.H. Chan School of Public Health. His research focuses on antithrombotic therapies in atrial fibrillation, acute and chronic heart failure, and critical care cardiology. Learning Objectives: Implement evidence-based risk stratification strategies to optimize thrombosis prevention and management in ACS, AF, and SSP: Apply CHA₂DS₂-VASc and HAS-BLED scoring to accurately identify AF patients at high risk of stroke and determine appropriate anticoagulation therapy​. Utilize validated risk assessment tools, such as GRACE and TIMI scores, to guide individualized antithrombotic treatment decisions in ACS and SSP​. Improve detection and management of asymptomatic AF (AAF) and undiagnosed stroke-risk patients, ensuring timely initiation of anticoagulation​. Individualize antithrombotic therapy selection and dosing to maximize efficacy while mitigating bleeding risks in ACS, AF, and SSP: Optimize DOAC dosing and selection to ensure stroke prevention without increasing bleeding risk, reducing underuse and inappropriate substitution with antiplatelets​. Address barriers to adherence and improve patient engagement in shared decision-making, ensuring informed choices about anticoagulation​. Reduce inappropriate modifications of anticoagulant therapy due to bleeding concerns, ensuring alignment with clinical guidelines and real-world outcomes​. Continuing Education Information Please read the full disclosure and accreditation information here before watching: https://app.medalleducation.com/event...